Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted M Ross

Showing results (21-30 of 345) with videos related to

Pageof 35
Sort By:
Expert Review of Vaccines|March 23, 2021
Evolution of A(H1N1) pdm09 influenza virus masking by glycosylationPan Ge, Ted M Ross
Cell Host & Microbe|November 9, 2023
Putting the pieces together: Chimeric virus strategy decode Dengue virus 3 antibody responsesNaoko Uno, Ted M Ross
Journal of Virology|March 15, 2022
Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019James D Allen, Ted M Ross
Vaccine|May 19, 2025
Corrigendum to "Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses" [Vaccine 38 (4) (2020) 830-839]Ivette A Nuñez, Ted M Ross
Vaccine|February 16, 2011
A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferretsBrendan M Giles, Ted M Ross
Journal of Immunology Research|March 14, 2017
Generation of Monoclonal Antibodies against Immunoglobulin Proteins of the Domestic Ferret (<i>Mustela putorius furo</i>)Greg A Kirchenbaum, Ted M Ross
Human Vaccines & Immunotherapeutics|September 27, 2019
2018 ISV Congress: advances in the 100 years since the world's deadliest pandemicDenise L Doolan, Ted M Ross
Current HIV Research|November 30, 2007
Antibody neutralizationKelly Stefano Cole, Ted M Ross
Vaccine|November 18, 2019
Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of virusesIvette A Nuñez, Ted M Ross
Cleveland Clinic Journal of Medicine|September 4, 2024
Respiratory viruses: Preventive and therapeutic approaches to diverse pathogensGiuseppe A Sautto, Ted M Ross
Pageof 35

Showing results (21-30 of 345) with videos related to

Sort By:
Pageof 35
Expert Review of Vaccines|March 23, 2021
Evolution of A(H1N1) pdm09 influenza virus masking by glycosylationPan Ge, Ted M Ross
Cell Host & Microbe|November 9, 2023
Putting the pieces together: Chimeric virus strategy decode Dengue virus 3 antibody responsesNaoko Uno, Ted M Ross
Journal of Virology|March 15, 2022
Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019James D Allen, Ted M Ross
Vaccine|May 19, 2025
Corrigendum to "Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses" [Vaccine 38 (4) (2020) 830-839]Ivette A Nuñez, Ted M Ross
Vaccine|February 16, 2011
A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferretsBrendan M Giles, Ted M Ross
Journal of Immunology Research|March 14, 2017
Generation of Monoclonal Antibodies against Immunoglobulin Proteins of the Domestic Ferret (<i>Mustela putorius furo</i>)Greg A Kirchenbaum, Ted M Ross
Human Vaccines & Immunotherapeutics|September 27, 2019
2018 ISV Congress: advances in the 100 years since the world's deadliest pandemicDenise L Doolan, Ted M Ross
Current HIV Research|November 30, 2007
Antibody neutralizationKelly Stefano Cole, Ted M Ross
Vaccine|November 18, 2019
Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of virusesIvette A Nuñez, Ted M Ross
Cleveland Clinic Journal of Medicine|September 4, 2024
Respiratory viruses: Preventive and therapeutic approaches to diverse pathogensGiuseppe A Sautto, Ted M Ross
Pageof 35